dr. hussain on the treatment of nonmetastatic crpc
Published 6 years ago • 43 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
5:55
the future of treatment for nonmetastatic crpc
-
21:25
an update on the prosper trial: focusing on nonmetastatic crpc
-
1:18
dr. hussain on the clinical impact of the profound trial in mcrpc
-
1:50
dr. hussain on the rationale to target the dna repair pathway in mcrpc
-
1:45
dr. choudhury on antiandrogen treatment selection in nonmetastatic crpc
-
1:47
dr. hussain on potential of enzalutamide in prostate cancer
-
7:46
treating non-metastatic castrate resistant prostate cancer | ask a prostate expert, mark scholz, md
-
21:13
treating aggressive prostate cancer with maha hussain, md
-
26:28
advances in non-metastatic prostate cancer: navigating arpis and precision diagnostics
-
0:51
dr. gomella on the fda approval of enzalutamide in nonmetastatic crpc
-
2:00
dr. shore on the tolerability of darolutamide in nonmetastatic crpc
-
1:11
dr. maha hussain on novel approaches in prostate cancer
-
8:47
treatment of metastatic crpc
-
1:01
dr. hussain on interest in using parp inhibitors in prostate cancer
-
1:13
dr. hussain on the importance of genomic profiling in mcrpc
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
1:35
dr. hussain on the importance of next generation sequencing in prostate cancer
-
6:51
understanding nonmetastatic crpc: an overview
-
1:10
dr. gomella on the fda approval of apalutamide for nonmetastatic crpc
-
6:50
ep. 6: identifying nonmetastatic crpc
-
0:44
dr. wise on the fda approval of apalutamide in non-metastatic crpc
-
0:57
dr. dorff on choosing between therapies in nonmetastatic crpc